Fermi Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 6, 2026 to Discuss Your Rights - FRMI [Accessibility Statement] Skip NavigationNEW YORK, Feb. 18, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Fermi Inc. ("Fermi Inc." or the "Company") (NASDAQ: FRMI) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Fermi Inc. investors who were adversely affected by alleged securities fraud. This lawsuit ...

Klarna Group plc Class Action: Levi & Korsinsky Reminds Klarna Group plc Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 20, 2026 - KLAR [Accessibility Statement] Skip NavigationNEW YORK, Feb. 18, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Klarna Group plc ("Klarna Group plc" or the "Company") (NYSE: KLAR) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Klarna Group plc investors who were a ...

Core Viewpoint - A class action securities lawsuit has been filed against agilon health, inc. (AGL) for alleged securities fraud affecting investors between February 26, 2025, and August 4, 2025 [1] Group 1: Lawsuit Details - The lawsuit claims that defendants made false statements and concealed information regarding the company's 2025 guidance, which was deemed unachievable due to known industry challenges [1] - It is alleged that defendants overstated the financial benefits from strategic actions taken by agilon to mitigate risks, leading to materially false and misleading statements about the company's business and prospects [1] Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until March 2, 2026, to request appointment as lead plaintiff, with no costs or obligations to participate in the lawsuit [1] - Levi & Korsinsky, LLP, the law firm handling the case, has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years [1]

Oracle Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 6, 2026 to Discuss Your Rights - ORCL [Accessibility Statement] Skip NavigationNEW YORK, Feb. 18, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Oracle Corporation ("Oracle" or the "Company") (NYSE: ORCL) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Oracle investors who were adversely affected by alleged securities fraud between June 12, 2 ...

Ultragenyx Pharmaceutical Inc. Class Action: Levi & Korsinsky Reminds Ultragenyx Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 6, 2026 - RARE [Accessibility Statement] Skip NavigationNEW YORK, Feb. 18, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Ultragenyx Pharmaceutical Inc. ("Ultragenyx" or the "Company") (NASDAQ: RARE) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Ultragenyx investors wh ...

Core Insights - Hagens Berman is investigating BellRing Brands, Inc. (NYSE: BRBR) for alleged securities fraud related to misleading statements about sales growth drivers [1] - The lawsuit claims that BellRing's reported sales growth was artificially inflated due to retailers hoarding inventory, leading to a significant drop in share price when the truth was revealed [1] Company Allegations - The lawsuit alleges that BellRing and its executives misled investors regarding the sustainability and drivers of its sales growth, as well as the competitive landscape affecting demand for its products [1] - Key admissions from BellRing's CFO indicated that retailers were hoarding inventory to avoid stock shortages, which was downplayed as a non-issue for consumption [1] Financial Impact - Following the release of disappointing Q3 2025 financial results, BellRing's share price fell by $17.46, a decrease of 33% [1] - The lawsuit claims that the strong sales reported during the class period were not reflective of actual consumer demand but rather due to temporary inventory stockpiling by retailers [1] Next Steps for Investors - Investors who suffered losses from BRBR shares purchased between November 19, 2024, and August 4, 2025, are encouraged to contact Hagens Berman before the lead plaintiff deadline of March 23, 2026 [1]

Core Viewpoint - A class action lawsuit has been filed against Klarna Group plc for failing to disclose material financial risks during its IPO, impacting investors who purchased securities between September 7, 2025, and December 22, 2025 [1][3]. Company Overview - Klarna Group plc, headquartered in Sweden, provides Buy Now, Pay Later (BNPL) solutions, facilitating loans for small retail transactions between consumers and merchants [2]. Legal Allegations - The lawsuit claims that Klarna's IPO documents did not adequately disclose significant financial risks, particularly the potential for a sharp increase in loss reserves due to the high-risk profiles of its customer base [3]. - It is alleged that many customers were experiencing financial hardships and were unsophisticated, increasing the likelihood of defaulting on loans [3]. Market Reaction - Following a report on November 18, 2025, indicating that Klarna had set aside more provisions for credit losses than the market anticipated, the company's share price fell by 21%, closing at $31.31, down from the IPO price of $40 [4].

Core Points - A class action lawsuit has been filed against CoreWeave, Inc. and certain senior executives for securities fraud following significant stock drops due to potential violations of federal securities laws [1][3] - Investors are encouraged to seek additional information regarding the lawsuit and their legal options [2][9] Company Overview - CoreWeave is an AI-focused cloud computing company that operates data centers providing high-performance GPU infrastructure [4] - The company relies on partnerships, including a merger agreement with Core Scientific announced on July 7, 2025 [4] Allegations and Stock Performance - CoreWeave allegedly overstated its ability to meet customer demand and concealed significant construction delays at its data centers [5] - On October 30, 2025, CoreWeave's stock dropped by $8.87 per share (over 6%) after the merger with Core Scientific was terminated due to insufficient shareholder votes [6] - Following a revenue guidance reduction on November 10, 2025, the stock fell by $17.22 per share (over 16%) due to delays from a third-party data center developer [7] - A report on December 15, 2025, indicated further delays in a major data center project, causing the stock to drop by $2.85 per share (over 3%) [8]

Core Viewpoint - A class action lawsuit has been filed against Plug Power Inc. and certain senior executives for securities fraud following significant stock drops attributed to potential violations of federal securities laws [1][3]. Company Overview - Plug Power provides hydrogen fuel cell turnkey solutions for electric mobility and stationary power markets and develops infrastructure such as hydrogen production plants [4]. Legal Proceedings - Investors have until April 3, 2026, to request to lead the case in the U.S. District Court for the Northern District of New York, under the case caption Ortolani v. Plug Power Inc., et al., No. 1:26-cv-00165 [3]. Allegations - The lawsuit claims that Plug Power materially overstated the likelihood of receiving a $1.66 billion loan guarantee from the U.S. Department of Energy, which was intended to finance the construction of hydrogen production facilities [4]. Stock Performance - On October 7, 2025, Plug Power's stock dropped by $0.26 per share (6.3%) following the announcement of the abrupt departure of its CEO and President [5]. - On November 10, 2025, the stock fell by $0.09 per share (3.4%) after the company suspended activities under the DOE loan program [6]. - A further drop of $0.48 per share (17.6%) occurred on November 14, 2025, after reports confirmed the suspension of plans to construct hydrogen production facilities, jeopardizing the $1.66 billion DOE loan [7].

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][3]. Company Overview - Ardent Health, Inc. operates acute care hospitals and other healthcare facilities, with a focus on the collection of accounts receivable [4]. Allegations of Fraud - The lawsuit claims that Ardent Health misrepresented its process for determining the collectability of accounts receivable, stating it relied on "detailed reviews of historical collections," while in reality, it used a "180-day cliff" method to reserve accounts, leading to inflated receivable reports [4]. Stock Performance Impact - On November 12, 2025, Ardent Health disclosed a $43 million revenue decrease for the quarter and increased its professional liability reserves by $54 million, resulting in a stock price drop of $4.75 per share, or over 33%, from $14.05 to $9.30 [5]. Legal Proceedings - Investors have until March 9, 2026, to request to lead the case in the U.S. District Court for the Middle District of Tennessee, under the caption Postiwala v. Ardent Health, Inc., et al. [3].